School of Medicine
Showing 1-10 of 228 Results
-
Myriam Amsallem
Postdoctoral Research Fellow, Cardiovascular Medicine
Bio Dr. Myriam Amsallem, a cardiologist specialized in cardiac imaging, completed her training in Paris VII University, France. She has an interest in heart failure, cardioimmunology and early detection of pulmonary hypertension and right heart failure using imaging and circulating biomarkers. She is currently working on studies at Stanford University with Marie Lannelongue Hospital (French reference center for Pulmonary Hypertension, France) on studies on right heart remodeling with the goal of understanding the influence of inflammation and finding early biomarkers of remodeling. She also has a special interest in educational projects to improve the quality of imaging methodology.
-
Lucia Aronica
Postdoctoral Research Fellow, SCRDP/ Heart Disease Prevention
Bio Over the past ten years my research has focused on the field of epigenetics, which investigates how environmental factors can affect gene activity thereby impacting our health and predisposition to diseases. Unlike genetic factors, epigenetic modifications are flexible and can store cell memories of life exposures such as diet, stress or environmental toxins. As such, they hold great potential in personalized health as biomarkers for exposure-driven chronic diseases such as obesity, diabetes, cardiovascular disease, and cancer.
I am currently leading the epigenetic analysis of the largest study ever undertaken in personalized nutrition on low carb vs. low fat diets – the DIETFITS study by Prof Christopher Gardner. My primary goal is to understand how weight-loss affects gene activity through epigenetic modifications, and whether we can use these modifications to predict diet response for personalized weight-loss strategies.
I also teach Nutritional Genomics at Stanford Continuing Studies, Stanford Sport Medicine and at the Stanford Center for Professional Development. An award-winning science communicator, I use creative forms of communication such as digital drawings to explain complex topics from the world of epigenetics and science. Finally, I serve as an advisor for personal genomics companies, self-tracking technology businesses, and companies interested in investing in precision health research.
